Aadi Bioscience, Inc. (AADI) DCF Valuation

Aadi Bioscience, Inc. (AADI) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Aadi Bioscience, Inc. (AADI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore Aadi Bioscience, Inc.'s (AADI) financial prospects with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to calculate Aadi Bioscience, Inc.'s (AADI) intrinsic value and enhance your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .7 14.0 1.0 15.2 24.4 34.5 49.0 69.4 98.5 139.6
Revenue Growth, % 0 1769.16 -92.86 1421.6 60.06 41.8 41.8 41.8 41.8 41.8
EBITDA -24.4 -2.5 -109.1 -60.1 -65.4 -28.9 -40.9 -58.0 -82.3 -116.7
EBITDA, % -3263.56 -17.75 -10914.7 -395.14 -268.4 -83.55 -83.55 -83.55 -83.55 -83.55
Depreciation .1 .2 .3 .2 .2 2.8 4.0 5.7 8.0 11.4
Depreciation, % 10.21 1.26 27.6 1.04 0.69393 8.16 8.16 8.16 8.16 8.16
EBIT -24.5 -2.7 -109.4 -60.3 -65.5 -28.9 -41.0 -58.2 -82.5 -117.0
EBIT, % -3273.78 -19.01 -10942.3 -396.18 -269.09 -83.8 -83.8 -83.8 -83.8 -83.8
Total Cash 38.5 4.5 149.0 172.6 108.8 29.8 42.3 60.0 85.0 120.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 14.1 .0 1.9 5.5
Account Receivables, % 0 101.06 0 12.24 22.53
Inventories -.3 .0 .0 1.9 6.4 .0 .1 .1 .1 .2
Inventories, % -38.04 0 0 12.23 26.39 0.11672 0.11672 0.11672 0.11672 0.11672
Accounts Payable .4 2.4 6.4 3.5 5.9 15.4 21.9 31.0 43.9 62.3
Accounts Payable, % 58.72 17.09 643.9 23.13 24.22 44.63 44.63 44.63 44.63 44.63
Capital Expenditure -.2 .0 .0 -.4 -4.0 -3.8 -5.4 -7.7 -10.9 -15.5
Capital Expenditure, % -31.64 0 -4.6 -2.92 -16.31 -11.09 -11.09 -11.09 -11.09 -11.09
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -24.5 -2.7 -109.4 -56.8 -65.5 -28.6 -40.6 -57.5 -81.6 -115.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -24.0 -15.0 -91.0 -63.7 -75.2 -17.5 -39.5 -56.0 -79.3 -112.5
WACC, % 6.37 6.37 6.37 6.35 6.37 6.36 6.36 6.36 6.36 6.36
PV UFCF
SUM PV UFCF -242.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -115
Terminal Value -2,631
Present Terminal Value -1,932
Enterprise Value -2,175
Net Debt -62
Equity Value -2,113
Diluted Shares Outstanding, MM 27
Equity Value Per Share -78.51

What You Will Get

  • Real AADI Financial Data: Pre-filled with Aadi Bioscience's historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Aadi Bioscience’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Clinical Inputs: Adjust essential parameters such as patient demographics, treatment efficacy, and cost structures.
  • Instant Valuation Metrics: Automatically computes intrinsic value, NPV, and various financial outputs in real-time.
  • High-Precision Analytics: Incorporates Aadi Bioscience's actual financial data for accurate valuation assessments.
  • Effortless Scenario Testing: Easily explore different hypotheses and analyze their impacts side by side.
  • Efficiency Booster: Streamline the valuation process without the hassle of creating intricate models from the ground up.

How It Works

  • Step 1: Download the prebuilt Excel template with Aadi Bioscience’s data included.
  • Step 2: Explore the pre-filled sheets and understand the key metrics.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Aadi Bioscience’s intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose Aadi Bioscience's Calculator?

  • Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for Aadi Bioscience, Inc. (AADI).
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes Aadi Bioscience’s intrinsic value and Net Present Value.
  • Preloaded Data: Utilizes historical and forecasted data for precise calculations.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focused on Aadi Bioscience, Inc. (AADI).

Who Should Use This Product?

  • Investors: Accurately estimate Aadi Bioscience's fair value before making investment decisions.
  • CFOs: Leverage a professional-grade DCF model for financial reporting and analysis specific to Aadi Bioscience (AADI).
  • Consultants: Quickly adapt the template for valuation reports related to Aadi Bioscience (AADI) for clients.
  • Entrepreneurs: Gain insights into financial modeling techniques utilized by leading biotech firms.
  • Educators: Use it as a teaching tool to demonstrate valuation methodologies in the biotech sector.

What the Template Contains

  • Pre-Filled DCF Model: Aadi Bioscience’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Aadi Bioscience’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.